This is a "connection" page, showing publications co-authored by Daryl Bohning and Xingbao Li.
Using interleaved transcranial magnetic stimulation/functional magnetic resonance imaging (fMRI) and dynamic causal modeling to understand the discrete circuit specific changes of medications: lamotrigine and valproic acid changes in motor or prefrontal effective connectivity. Psychiatry Res. 2011 Nov 30; 194(2):141-8.
Interleaved transcranial magnetic stimulation and fMRI suggests that lamotrigine and valproic acid have different effects on corticolimbic activity. Psychopharmacology (Berl). 2010 Apr; 209(3):233-44.
Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology. 2004 Jul; 29(7):1395-407.
Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol Psychiatry. 2004 May 01; 55(9):882-90.
Mechanisms and the current state of transcranial magnetic stimulation. CNS Spectr. 2003 Jul; 8(7):496-514.
Prefrontal cortex transcranial magnetic stimulation does not change local diffusion: a magnetic resonance imaging study in patients with depression. Cogn Behav Neurol. 2003 Jun; 16(2):128-35.
Mechanisms and state of the art of transcranial magnetic stimulation. J ECT. 2002 Dec; 18(4):170-81.
Imaging the neural mechanisms of TMS neglect-like bias in healthy volunteers with the interleaved TMS/fMRI technique: preliminary evidence. Front Hum Neurosci. 2012; 6:326.
Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress Anxiety. 2004; 19(4):249-56.